Search

Your search keyword '"Aisner J"' showing total 521 results

Search Constraints

Start Over You searched for: Author "Aisner J" Remove constraint Author: "Aisner J"
521 results on '"Aisner J"'

Search Results

201. Phase II trial of gemcitabine plus cisplatin in patients with metastatic urothelial cancer.

202. The use of carboplatin and paclitaxel with daily radiotherapy in patients with locally advanced squamous cell carcinomas of the head and neck.

203. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group.

204. Overcoming bcl-2- and p53-mediated resistance in prostate cancer.

205. Phase I trial, including pharmacokinetic and pharmacodynamic correlations, of combination paclitaxel and carboplatin in patients with metastatic non-small-cell lung cancer.

206. Dose-response trial of megestrol acetate in advanced breast cancer: cancer and leukemia group B phase III study 8741.

207. Dihydro-5-azacytidine and cisplatin in the treatment of malignant mesothelioma: a phase II study by the Cancer and Leukemia Group B.

208. Second primary cancers related to smoking and treatment of small-cell lung cancer. Lung Cancer Working Cadre.

209. Effect of 13-cis-retinoic acid and alpha-interferon on transforming growth factor beta1 in patients with rising prostate-specific antigen.

210. A pilot trial of paclitaxel, carboplatin, and concurrent radiotherapy for unresectable squamous cell carcinoma of the head and neck.

211. Paclitaxel in head and neck and other cancers: future prospects.

212. Paclitaxel in head and neck cancer and other tumor types: chairmen's introduction.

213. Chemoradiotherapy in non-small cell lung cancer: paclitaxel/carboplatin/radiotherapy in regionally advanced disease.

214. Paclitaxel and carboplatin in metastatic non-small cell lung cancer: preliminary results of a phase I study.

215. Pharmacokinetics of paclitaxel and carboplatin in combination.

216. Paclitaxel and carboplatin with and without filgrastim support in patients with metastatic non-small cell lung cancer.

217. Current approach to malignant mesothelioma of the pleura.

218. Combined modalities in the treatment of head and neck cancers.

219. Chemoradiotherapy for the treatment of regionally advanced head and neck cancers.

220. Combined chemotherapy and radiation in locally advanced non-small cell lung cancer.

221. Etoposide: current status and future perspectives in the management of malignant neoplasms.

223. Immunomodulation of interleukin-2 by cyclophosphamide: a phase IB trial.

224. Treatment of limited-disease small cell lung cancer.

225. Protein calorie malnutrition and cancer therapy.

226. Carboplatin in the treatment of squamous cell head and neck cancers.

227. Potential applications of high-dose megestrol acetate in breast cancer.

228. Long-term results of a combined modality approach in treating inflammatory carcinoma of the breast.

229. A phase I/II study of high-dose megestrol acetate in the treatment of metastatic breast cancer.

230. Phase I/II study of cyclophosphamide, doxorubicin, fluorouracil, and leucovorin for treatment of metastatic adenocarcinoma.

231. Etoposide. Current and future status.

232. Current status of high-dose progestins in breast cancer.

233. Appetite stimulation and weight gain with megestrol acetate.

234. Small bowel obstruction as a late complication of the treatment of Hodgkin's disease.

235. Treatment of cancer anorexia with megestrol acetate: impact on quality of life.

237. Mesna, doxorubicin, ifosfamide, dacarbazine (MAID) regimen for adults with advanced sarcoma.

238. A feasibility study of intensive CAF as outpatient adjuvant therapy for stage II breast cancer in a cooperative group: CALGB 8443.

239. Carboplatin in malignant mesothelioma: a phase II study of the Cancer and Leukemia Group B.

241. A randomized trial of leukocyte-depleted platelet transfusion to modify alloimmunization in patients with leukemia.

242. Prospective validation of a pharmacologically based dosing scheme for the cis-diamminedichloroplatinum(II) analogue diamminecyclobutanedicarboxylatoplatinum.

243. Empiric antibiotic therapy.

244. Mastectomy as an adjuvant to chemotherapy for locally advanced or metastatic breast cancer.

245. Carcinomatous leptomeningitis in small cell lung cancer: a clinicopathologic review of the National Cancer Institute experience.

246. Doxorubicin, cyclophosphamide, etoposide and platinum, doxorubicin, cyclophosphamide and etoposide for small-cell carcinoma of the lung.

247. A comparison of carboplatin plus methotrexate versus methotrexate alone in patients with recurrent and metastatic head and neck cancer.

248. Role of chemotherapy in small cell lung cancer: a consensus report of the International Association for the Study of Lung Cancer workshop.

249. Staging, prognostic factors, and special considerations in small cell lung cancer.

250. Long-term follow-up patients with leukemia receiving platelet transfusions: identification of a large group of patients who do not become alloimmunized.

Catalog

Books, media, physical & digital resources